You are here

Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.

Pubmed ID: 
32500973
Year: 
2020
Month: 
07
Volume: 
182
Issue: 
7
Citation: 
Wenger TL, Bly RA, Wu N, Albert CM, Park J, Shieh J, Chenbhanich J, Heike CL, Adam MP, Chang I, Sun A, Miller DE, Beck AE, Gupta D, Boos MD, Zackai EH, Everman D, Ganapathi S, Wilson M, Christodoulou J, Zarate YA, Curry C, Li D, Guimier A, Amiel J, Hakonarson H, Webster R, Bhoj EJ, Perkins JA, Dahl JP, Dobyns WB. Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy. American journal of medical genetics. Part A 182 (7) : 1576 - 1591(2020) PubMed